(Q35052920)

6 August 2017

1 reference

4 August 2019

1 reference

systematic review

1 reference

title

The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis (English)

1 reference

6 August 2017

1 reference

4 August 2019

1 reference

1 reference

1 reference

1 reference

5

Carol Friesen

1 reference

6 August 2017

Brett L Houston

2

0 references

Ryan Zarychanski

object named as

Ryan Zarychanski

11

0 references

Deborah J. Cook

9

object named as

Deborah J Cook

1 reference

6 August 2017

8

Alexis F Turgeon

1 reference

6 August 2017

Emily Rimmer

1

1 reference

6 August 2017

Anand Kumar

3

1 reference

6 August 2017

Ahmed M Abou-Setta

4

1 reference

6 August 2017

John C Marshall

6

1 reference

6 August 2017

Gail Rock

7

1 reference

6 August 2017

Donald S Houston

10

1 reference

6 August 2017

language of work or name

1 reference

20 December 2014

4 references

6 August 2017

23 March 2019

25 June 2019

4 August 2019

4 references

6 August 2017

23 March 2019

25 June 2019

4 August 2019

18

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

699

1 reference

Creative Commons Attribution

6 August 2017

copyright license

3 references

23 March 2019

25 June 2019

4 August 2019

0 references

on focus list of Wikimedia project

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13054-014-0699-2

0 references

cites work

Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Severe sepsis and septic shock

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Blood purification and mortality in sepsis: a meta-analysis of randomized trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Coagulation biomarkers in critically ill patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Landmark survival as an end-point for trials in critically ill patients--comparison of alternative durations of follow-up: an exploratory analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Molecular biology of inflammation and sepsis: a primer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Apheresis in patients with severe sepsis and multi organ dysfunction syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Extracorporeal therapies in the treatment of sepsis: experience and promise

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

The hematologic system as a marker of organ dysfunction in sepsis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

The epidemiology of sepsis in the United States from 1979 through 2000

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Preventing complications of central venous catheterization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Efficacy and safety of recombinant human activated protein C for severe sepsis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Role of exchange transfusion in the treatment of severe septicemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

APACHE II: a severity of disease classification system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Plasmapheresis for fulminant meningococcemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Plasma and whole blood exchange in meningococcal sepsis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0699-2

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0699-2

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0699-2

A randomised controlled trial of plasma filtration in severe paediatric sepsis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318234

Complications of therapeutic plasma exchange: experience with 4857 treatments

25 October 2018

1 reference

12 December 2020

Outcome of patients with sepsis and septic shock after ICU treatment

1 reference

12 December 2020

Protective effects of activated protein C in sepsis

1 reference

12 December 2020

Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group

1 reference

12 December 2020

Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties

1 reference

12 December 2020

Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial

1 reference

12 December 2020

Plasmapheresis for meningococcemia with disseminated intravascular coagulation

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Plasmapheresis in the treatment of primary septic shock in humans

1 reference

12 December 2020

Plasma exchange in patients with septic shock including acute renal failure

1 reference

12 December 2020

10.1186/S13054-014-0699-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference